The 36th World Congress of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2026) was recently held in London, UK. As one of the leading international events in obstetric and gynecological ultrasound, the congress brought together more than 2,500 clinicians, experts, researchers, and industry professionals from 121 countries to explore the latest developments, clinical applications, and future directions in women’s health ultrasound.

As a Diamond Sponsor of ISUOG 2026, SonoScape presented its comprehensive portfolio of ultrasound solutions across a wide range of obstetric and gynecological clinical settings. Centered around three key directions: point-of-care accessibility, advanced imaging, and AI technologies, the company showcased solutions spanning bedside POCUS, advanced fetal medicine imaging, AI-enabled ultrasound workflows, and specialized gynecological applications.

Rather than focusing solely on individual products, SonoScape’s presence at ISUOG 2026 reflected three directions in which obstetric and gynecological ultrasound is evolving: going further into frontline clinical care, seeing more in complex diagnostic scenarios, and working smarter through AI technologies.

These three directions: Go Further, See More, Work Smarter, came together across SonoScape’s clinical demonstrations, expert sessions, booth, VIP Lounge and SonoElite Club program, highlighting an increasingly comprehensive approach to women’s health ultrasound.

Go Further: Expanding Point-of-Care Obstetric Ultrasound with Portable Ultrasound and SonoFast OB

One of the key topics at ISUOG 2026 was the growing role of point-of-care ultrasound (POCUS) in obstetrics, particularly in situations where rapid assessment can directly inform clinical decision-making.

During the POCUS OB Workshop & Scan Demonstration, Prof. Liona C. Poon, President of ISUOG, demonstrated the SonoScape E11, a high-end laptop ultrasound system, together with SonoFast OB, a guided and protocol-based workflow developed in alignment with the principles of the ISUOG POCUS OB guidelines.



SonoFast OB is designed to guide clinicians through focused obstetric POCUS assessments around key clinical questions, including fetal viability, fetal presentation, placental assessment, cervical length, amniotic fluid evaluation, and risk assessment. By structuring the examination around clinically relevant steps, the solution aims to support faster and more consistent focused assessments at the bedside.



For SonoScape, this represents a broader shift in the meaning of portability: from simply bringing an ultrasound system to the bedside to bringing structured, high-quality obstetric assessment capabilities into frontline clinical practice. With its combination of portability, imaging performance, and guided workflow, the E11 and SonoFast OB demonstrate SonoScape’s continued exploration of how ultrasound can support more immediate clinical decisions wherever care takes place.

See More: Advancing Fetal Cardiac Imaging with High-End Ultrasound Platforms

Fetal cardiac imaging remains one of the most technically demanding and clinically significant areas of obstetric ultrasound. At ISUOG 2026, fetal cardiac masterclasses and live scanning demonstrations were among the highlights of SonoScape’s academic program, bringing together expert perspectives and hands-on experience in advanced fetal cardiac assessment.

During the Workshop & Scan Demonstration, Prof. Enrique Gil Guevara (Peru), ISUOG Ambassador in Latin-America, conducted an in-depth demonstration of fetal cardiac scanning, highlighting the value of advanced ultrasound imaging in visualizing fetal cardiac structures and supporting the assessment of complex cases.



At the same time, Prof. Zhiyun Tian from Children’s Hospital of Philadelphia (CHOP), USA brought her masterclass, “Mastering Fetal Cardiac Imaging: From Expert Scanning to Diagnostic Confidence,” to the SonoScape Lounge. As a specialist in fetal cardiovascular imaging, Prof. Tian provided an in-depth, hands-on demonstration using SonoScape’s latest Autra Series, guiding participants through the expert approach to fetal cardiac scanning, from obtaining standard views to understanding how systematic scanning can contribute to greater diagnostic confidence.



Together, these expert-led sessions offered clinicians a closer look at both the art and methodology of fetal cardiac imaging, while demonstrating the role of advanced ultrasound platforms in supporting increasingly detailed fetal assessments.

Work Smarter: Empowering Clinical Decision-Making with AI and the S-Fetus Workflow

As ultrasound examinations become increasingly sophisticated, another question is gaining importance: how can technology help clinicians manage growing diagnostic demands without adding unnecessary complexity?

At the SonoScape-sponsored Lunch Symposium, Prof. Andrea Dall’Asta from Italy discussed the role of AI and advanced technologies in screening and referral. With the Next-Generation S-Fetus, SonoScape is advancing a shift in obstetric ultrasound from experience-dependent workflows toward more standardized and AI-assisted approaches, helping clinicians work more efficiently and consistently, while providing greater support and confidence in increasingly complex and demanding clinical settings.



The value of AI is no longer limited to individual automated functions. Instead, it is becoming increasingly embedded across the clinical workflow, helping reduce repetitive tasks, improve examination efficiency and consistency, and support clinicians throughout screening, follow-up, and referral.

SonoElite Club: Connecting Global Expertise Across the Field

Beyond the Masterclasses and Live Scan Demonstrations, the SonoElite Club brought a broad range of academic topics to ISUOG 2026, connecting 15 obstetric and gynecological ultrasound experts from the UK, Sweden, Australia, Egypt, China, the United States, Germany, and other countries and regions. Across dedicated sessions and clinical discussions, experts shared perspectives on some of the most relevant developments shaping women’s health ultrasound.

The program spanned a wide range of clinical areas, including obstetrics, gynecology, fetal medicine, gynecologic oncology, endometriosis, twin pregnancy, fetal urinary tract abnormalities, fetal cardiac imaging, AI-enabled ultrasound workflows, contrast-enhanced ultrasound, and microvascular imaging, reflecting the breadth of SonoScape’s approach to women’s health ultrasound.



In standardized gynecological assessment, Prof. Ligita Jokubkiene, Chair of the ISUOG Education Committee from Sweden, shared insights into the application of O-RADS for adnexal mass assessment and clinical management. Combined with SonoScape’s latest S-ORADS feature, the session demonstrated how standardized risk stratification can be integrated into the ultrasound workflow, helping clinicians approach adnexal mass classification and management in a more structured and intuitive way.



Prof. George Condous, President of the World Federation of Ultrasound in Medicine and Biology (WFUMB) and a leading gynecological ultrasound expert from Australia, focused on the ultrasound diagnosis of endometriosis based on the IDEA international consensus. His session explored standardized approaches to scanning and assessing deep endometriosis. By incorporating the IDEA Protocol into its ultrasound systems, SonoScape aims to bring internationally recognized standardized assessment pathways closer to routine clinical practice and support more consistent gynecological ultrasound examinations.



In the field of gynecologic tumor assessment, Prof. Xinling Zhang from the Third Affiliated Hospital of Sun Yat-sen University, China, shared clinical experience with contrast-enhanced ultrasound in the evaluation of adnexal tumors. SonoScape’s advanced women’s health ultrasound platforms incorporate contrast-enhanced ultrasound (CEUS) and Super-Resolution Imaging CEUS (SRI CEUS) technologies, enabling clinicians to assess lesion perfusion, vascular distribution, and microvascular patterns. By extending assessment beyond morphology to include perfusion and microvascular information, these technologies can provide additional imaging insights for the differential diagnosis and risk stratification of complex adnexal tumors.



In fetal medicine and high-risk pregnancy, Prof. Asma Khalil, ISUOG Trustee and Chair of the ISUOG Twins & Multiple Pregnancy Special Interest Group, Professor of Obstetrics and Maternal-Fetal Medicine at St George’s, University of London, addressed the diagnosis and management of selective fetal growth restriction (sFGR) in twin pregnancies, as well as ongoing areas of debate. Her presentation covered the selection of growth charts, monitoring of intertwin weight differences, classification of sFGR in monochorionic twins, and prognostic assessment, offering an international perspective on the increasingly detailed management of high-risk twin pregnancies.



Prof. Mohamed Kamal Etman, ISUOG Ambassador in Middle East & North Africa from Egypt, focused on fetal urinary tract abnormalities, presenting a systematic approach spanning normal anatomy, abnormality classification, and diagnostic assessment. SonoScape’s advanced women’s health ultrasound platforms, with high-quality 2D imaging, sensitive blood-flow visualization, and 3D imaging capabilities, provide imaging support for the identification of complex fetal abnormalities, prenatal risk assessment, and clinical counseling.



Prof. Fang Yang, Professor and Director in the Department of Fetal Medicine and Prenatal Diagnosis, Zhujiang Hospital of Southern Medical University, China, shared clinical experience with low-flow, 3D volumetric blood-flow, and microvascular imaging technologies in applications including fetal lung and brain assessment, placental evaluation, and twin pregnancy. The session highlighted the potential of SonoScape’s multidimensional blood-flow imaging technologies to capture subtle microvascular perfusion signals and provide additional information for prenatal assessment.



AI was another important area of discussion. Prof. Liqun Sun from the Women’s Hospital School of Medicine, Zhejiang University, China, explored the clinical applications of AI in obstetric and gynecological ultrasound. Drawing on SonoScape’s intelligent solutions, including S-Fetus.Pilot, S-Fetal Brain, S-CNS, S-Follicle, S-ERA, and S-Uterus 3D, the session illustrated how AI can be integrated into clinical workflows ranging from standard plane acquisition and automated measurements to more comprehensive workflow support. These applications reflect the ongoing shift from experience-driven examinations toward intelligent assistance in women’s health ultrasound.

Beyond the experts mentioned above, Prof. Waldo Sepulveda from Chile, Prof. Marcin Wiecheć from Poland, Priv.-Doz. Dr. med. Michael Gembicki from Germany, Prof. Dr. med. Jan Weichert from Germany, Dr. Alan Treharne from the UK, and Dr. Farid Benaibouche from Algeria also joined the SonoElite Sessions, bringing diverse clinical perspectives from across the globe.



Their sessions covered a broad spectrum of topics in women’s health ultrasound, from O-RADS and IDEA to fetal urinary tract abnormalities, twin pregnancy, and fetal cardiac imaging; from CEUS, SRI CEUS, and microvascular imaging to AI-enabled clinical workflows. Together, the SonoElite Club and SonoScape Lounge brought international expertise, standardized clinical practice, and technological development into dialogue, offering a multidimensional platform for knowledge exchange and clinical exploration.

More than showcasing a broad portfolio of technologies, the program reflected SonoScape’s continued commitment to connecting clinical expertise, standardized practice, and technology development across the full spectrum of obstetric and gynecological care, and to advancing meaningful conversations around the evolving needs of women’s health.

Looking Ahead: From Chinese Innovation to the Global Stage

At ISUOG 2026, SonoScape not only presented a high-end portfolio spanning a broad range of obstetric and gynecological applications, but also demonstrated its continued commitment to addressing real clinical needs through a series of international expert sessions and live scanning demonstrations.

From E11 and SonoFast OB, extending obstetric POCUS further into frontline care, to the S80 / P80 Elite and Autra Series, helping clinicians see more in fetal cardiac imaging and complex fetal medicine, and the Next-Generation S-Fetus, bringing greater intelligence to the ultrasound workflow, SonoScape is building a comprehensive approach to women’s health ultrasound around advanced imaging, intelligent technologies, and greater accessibility, contributing Chinese expertise and capabilities to the development of women’s health ultrasound worldwide.



According to a recent industry report by Signify, SonoScape has risen to fourth place globally in obstetric and gynecological ultrasound. This growing position reflects years of sustained investment in technology development and deep engagement with clinical practice.

In the first half of 2026, SonoScape invested RMB 229 million in R&D, representing approximately 21.70% of its operating revenue, and has accumulated more than 1,600 intellectual property rights across China and international markets. With its four business lines in ultrasound, endoscopy, minimally invasive surgery, and cardiovascular intervention advancing in parallel, SonoScape’s products and services now reach more than 170 countries and regions worldwide. The company has also established localized operations across North America, Europe, and emerging markets, supported by increasingly refined global market planning and data-driven management.

Looking ahead, SonoScape will continue to work closely with clinicians and experts around the world, guided by international standards and grounded in real clinical needs. Through continued investment in imaging, intelligent technologies, and clinical applications, the company aims to help advance obstetric and gynecological ultrasound toward greater accuracy, intelligence, standardization, and accessibility, bringing the value of high-quality ultrasound to more clinicians and women worldwide.